tiprankstipranks
Sinopharm Group Co (SHTDY)
OTHER OTC:SHTDY
US Market

Sinopharm Group Co (SHTDY) Income Statement

Compare
21 Followers

Sinopharm Group Co Income Statement

Last quarter (Q2 2024), Sinopharm Group Co's total revenue was ¥147.46B, a decrease of -5.13% from the same quarter last year. In Q2, Sinopharm Group Co's net income was ¥2.28B. See Sinopharm Group Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
¥ 596.57B¥ 552.15B¥ 521.05B¥ 456.41B¥ 425.27B
Gross Profit
¥ 48.51B¥ 47.43B¥ 44.05B¥ 40.32B¥ 37.53B
Operating Expenses
¥ 28.30B¥ 24.23B¥ 22.61B¥ 20.54B¥ 19.03B
Depreciation and Amortization
¥ 4.43B¥ 4.17B¥ 3.92B¥ 3.60B¥ 3.11B
EBITDA
¥ 26.90B¥ 26.25B¥ 24.68B¥ 22.62B¥ 20.32B
Operating Income
¥ 20.21B¥ 20.60B¥ 19.71B¥ 17.76B¥ 16.14B
Other Income/Expenses
¥ -697.06M¥ -2.04B¥ -2.71B¥ -2.16B¥ -2.38B
Pretax Income
¥ 19.51B¥ 18.56B¥ 17.00B¥ 15.60B¥ 13.76B
Net Income
¥ 9.05B¥ 8.53B¥ 7.76B¥ 7.19B¥ 6.25B
Per Share Metrics
¥ ―¥ ―¥ ―¥ ―¥ ―
Basic EPS
¥ 2.90¥ 2.72¥ 2.49¥ 2.18¥ 2.04
Diluted EPS
¥ 2.90¥ 2.72¥ 2.49¥ 2.18¥ 2.04
Weighted Average Shares Outstanding
3.12B 3.13B 3.12B 3.30B 3.07B
Weighted Average Shares Outstanding (Diluted)
3.12B 3.13B 3.12B 3.30B 3.06B
Currency in CNY

Sinopharm Group Co Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis